• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    1.84 Down 0.05(2.65%) Feb 5, 4:00PM EST
    |After Hours : 1.94 Up 0.10 (5.43%) Feb 5, 6:59PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.4
    Mean Recommendation (last week):2.4
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:5.25
    Median Target:4.75
    High Target:11.00
    Low Target:2.00
    No. of Brokers:6

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 23, 2015RBC Capital MktsInitiated Outperform
    Jan 10, 2014WallachBethInitiated Buy
    Oct 3, 2013CowenInitiated Outperform
    Feb 1, 2011JMP SecuritiesDowngradeMkt OutperformMkt Perform
    Feb 1, 2011Canaccord GenuityDowngradeBuyHold
    Dec 3, 2010Rodman & RenshawDowngradeMkt PerformMkt Underperform
    Jul 16, 2010Rodman & RenshawDowngradeMkt OutperformMkt Perform
    Feb 2, 2010Jefferies & CoInitiated Buy
    Jun 24, 2009Rodman & RenshawInitiated Mkt Outperform
    Apr 3, 2008Cowen & CoInitiated Outperform

    More Upgrades & Downgrades for OREX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy1122
    Buy4555
    Hold2100
    Underperform1100
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.